In the cancer-immunity cycle [17], we found genes that inhibit the cycle, including the glioma-secreted and cell-surface immunosuppressive factors, TGFB1, VEGFA, ARG1, IL10, and CD70, they were highly expressed in the high-risk group and were positively correlated with the risk score. This evidence concerns the gene CD70 and glioma.